India markets close in 1 hour 47 minutes

    +147.72 (+0.30%)
  • Nifty 50

    +80.95 (+0.56%)

    -0.4950 (-0.66%)
  • Dow

    +305.10 (+0.90%)
  • Nasdaq

    +180.92 (+1.31%)

    -106,602.50 (-2.27%)
  • CMC Crypto 200

    -6.52 (-0.47%)
  • Hang Seng

    +202.89 (+0.70%)
  • Nikkei

    +40.68 (+0.14%)

    -0.5320 (-0.59%)

    -0.9159 (-0.89%)

    -0.0700 (-0.34%)

    +0.0114 (+0.79%)

    -0.3670 (-0.65%)

Shareholder Alert: Robbins LLP Announces That MultiPlan Corporation (MPLN) (f/k/a Churchill Capital Corp. III) is Being Sued for Misleading Shareholders

·3-min read

Shareholder rights law firm Robbins LLP announces that a purchaser of Churchill Capital Corp. III, n/k/a MultiPlan Corporation (NYSE: MPLN), filed a class action complaint against the Company and its officers and directors for alleged violations of the Securities Exchange Act of 1934 between July 12, 2020 and November 10, 2020. MultiPlan is a data analytics end-to-end cost management solutions provider to the U.S. healthcare industry.

If you suffered a loss due to MultiPlan Corporation's misconduct, click here.

MultiPlan Corporation (MPLN) Misled Shareholders About Its Business Prospects

According to the complaint, on July 12, 2020, Churchill III (a special purpose acquisition corporation) and MultiPlan announced their agreement to combine, announcing that the initial enterprise value for MultiPlan was approximately $11 billion or 12.9x estimated 2021 earnings before interest, taxes, depreciation and amortization. On September 18, 2020, Churchill III issued the proxy statement for the Merger (the "Proxy"), which noted the "competitive landscape" as a primary consideration on the board's recommendation that shareholders vote in favor of the Merger. The Proxy further touted MultiPlan's customer base and touted its projected revenue and earnings for 2021. The Proxy, however, contained materially false and misleading statements and omissions. Shareholders voted to approve the merger on October 7, 2020.

On November 11, 2020, Muddy Waters published a report revealing that MultiPlan was in the process of losing its largest client, UnitedHealthcare, which could cost the Company up to 35% of its revenue and 80% of its levered free cash flow within two years. UnitedHealthcare had purportedly launched a competitor, Naviguard, to reduce its business with MultiPlan and bring the over-priced and conflicted services offered by MultiPlan in-house. Muddy Waters also accused MultiPlan of obscuring its deteriorating financial position to investors by manipulating cash reserves to show inflated earnings figures in the years leading up to the Merger. Further, MultiPlan's previous private equity firm owners had "loot[ed] the business" for cash in the lead up to the Merger, which necessitated the sale to Churchill III as the owners could not find anyone else willing to buy the failing business after the deep cuts that led to deteriorating service quality and increased customer complaints. On this news, the price of Churchill III shares plummeted to just $6.12 per share, nearly 40% below the price at which shareholders could have redeemed their shares at the time of the shareholder vote on the Merger.

If you purchased shares of Churchill Capital Corp. III between July 12, 2020 and November 10, 2020, or were a Churchill III Class A common stock shareholder entitled to vote on Churchill III's merger with and acquisition of Polaris Parent Corp. and its consolidated subsidiaries (MultiPlan Corporation), you have until April 26, 2021, to ask the court to appoint you lead plaintiff for the class.

Contact us to learn more:
Lauren Levi
(800) 350-6003
Shareholder Information Form

Robbins LLP is a nationally recognized leader in shareholder rights law. To be notified if a class action against MultiPlan Corporation settles or to receive free alerts about companies engaged in wrongdoing, sign up for Stock Watch today.

Attorney Advertising. Past results do not guarantee a similar outcome.

View source version on


Lauren Levi
Robbins LLP
5040 Shoreham Place
San Diego, CA 92122
(800) 350-6003